Anti-inflammatory panacea? The expanding therapeutics of interleukin-1 blockade.
Purpose Of Review: Blockade of interleukin (IL)-1 signaling is one of the oldest biologic therapies, yet the use of these agents is on the rise as the role of IL-1 activation is being recognized in a wide spectrum of inflammatory disorders. This review will cover established and emerging uses of IL-...
| Published in: | Current Opinion in Rheumatology Vol. 28; no. 3; pp. 197 - 204 |
|---|---|
| Main Author: | |
| Format: | research Journal Article |
| Published: |
Lippincott Williams & Wilkins
May2016
|
| Online Access: | View this record in EBSCOhost |